Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Parry

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Mutation Research|August 1, 1993
Correlation of carcinogenic potency with mouse-skin 32P-postlabeling and muta-Rmouse lac Z- mutation data for DMBA and its K-region sulphur isostere: comparison with activities observed in standard genotoxicity assaysJ Ashby, D Brusick, B C Myhr, et al.
Medical Education|November 3, 2005
Consultant attitudes to undertaking undergraduate teaching duties: perspectives from hospitals serving a large medical schoolR G Hendry, G K Kawai, W E Moody, et al.
Mutagenesis|November 19, 2002
Detection and characterization of mechanisms of action of aneugenic chemicalsE M Parry, J M Parry, C Corso, et al.
Gut|April 15, 2003
Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagusS H Doak, G J S Jenkins, E M Parry, et al.
British Journal of Cancer|April 14, 2005
Fluorescence in situ hybridisation analysis of chromosomal aberrations in gastric tissue: the potential involvement of Helicobacter pyloriL Williams, G J S Jenkins, S H Doak, et al.
Carcinogenesis|October 1, 1994
Mutagenicity of o-anisidine to the bladder of lacI- transgenic B6C3F1 mice: absence of 14C or 32P bladder DNA adductionJ Ashby, J M Short, N J Jones, et al.
Oncogene|June 6, 2006
Radiation-induced transgenerational alterations in genome stability and DNA damageR C Barber, P Hickenbotham, T Hatch, et al.
Journal of Clinical Pathology|January 16, 2007
Immunohistochemical study of nuclear factor-kappaB activity and interleukin-8 abundance in oesophageal adenocarcinoma; a useful strategy for monitoring these biomarkersG J S Jenkins, J Mikhail, A Alhamdani, et al.
Mutation Research|June 12, 1996
Somatic recombination, gene amplification and cancerC Ramel, H Cederberg, J Magnusson, et al.
Mutation Research|January 22, 1998
Thalidomide: lack of mutagenic activity across phyla and genetic endpointsJ Ashby, H Tinwell, R D Callander, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Mutation Research|August 1, 1993
Correlation of carcinogenic potency with mouse-skin 32P-postlabeling and muta-Rmouse lac Z- mutation data for DMBA and its K-region sulphur isostere: comparison with activities observed in standard genotoxicity assaysJ Ashby, D Brusick, B C Myhr, et al.
Medical Education|November 3, 2005
Consultant attitudes to undertaking undergraduate teaching duties: perspectives from hospitals serving a large medical schoolR G Hendry, G K Kawai, W E Moody, et al.
Mutagenesis|November 19, 2002
Detection and characterization of mechanisms of action of aneugenic chemicalsE M Parry, J M Parry, C Corso, et al.
Gut|April 15, 2003
Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagusS H Doak, G J S Jenkins, E M Parry, et al.
British Journal of Cancer|April 14, 2005
Fluorescence in situ hybridisation analysis of chromosomal aberrations in gastric tissue: the potential involvement of Helicobacter pyloriL Williams, G J S Jenkins, S H Doak, et al.
Carcinogenesis|October 1, 1994
Mutagenicity of o-anisidine to the bladder of lacI- transgenic B6C3F1 mice: absence of 14C or 32P bladder DNA adductionJ Ashby, J M Short, N J Jones, et al.
Oncogene|June 6, 2006
Radiation-induced transgenerational alterations in genome stability and DNA damageR C Barber, P Hickenbotham, T Hatch, et al.
Journal of Clinical Pathology|January 16, 2007
Immunohistochemical study of nuclear factor-kappaB activity and interleukin-8 abundance in oesophageal adenocarcinoma; a useful strategy for monitoring these biomarkersG J S Jenkins, J Mikhail, A Alhamdani, et al.
Mutation Research|June 12, 1996
Somatic recombination, gene amplification and cancerC Ramel, H Cederberg, J Magnusson, et al.
Mutation Research|January 22, 1998
Thalidomide: lack of mutagenic activity across phyla and genetic endpointsJ Ashby, H Tinwell, R D Callander, et al.
Pageof 20